Y-mAbs Therapeutics to Present At 39th Annual J.P. Morgan Healthcare Conference 06 January 2021
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical... Read more
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical... Read more
DANSK BIOTEK conducted its first virtual members’ meeting ever on December 11 on the topic ‘Covid-19... Read more
ARTIKEL Antallet af private kliniske forsøg i Danmark står stille Trods flere års offentlig-privat... Read more
IO Biotech today announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough... Read more
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) (the “Company” or “Y-mAbs”) a commercial-stage biopharmaceutical... Read more
Press Release LINK Medical has today announced the acquisition of IRW Consulting AB (IRW), a Nordic CRO... Read more
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical... Read more
Y-mAbs Therapeutics, Inc. today announced a clinical update on omburtamab for the treatment of diffuse... Read more